Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nephros (NEPH) Amortization of Deferred Charges (2021 - 2025)

Historic Amortization of Deferred Charges for Nephros (NEPH) over the last 8 years, with Q3 2025 value amounting to $22000.0.

  • Nephros' Amortization of Deferred Charges rose 476.19% to $22000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $88000.0, marking a year-over-year decrease of 1926.61%. This contributed to the annual value of $91000.0 for FY2024, which is 4800.0% down from last year.
  • According to the latest figures from Q3 2025, Nephros' Amortization of Deferred Charges is $22000.0, which was up 476.19% from $20000.0 recorded in Q2 2025.
  • Nephros' Amortization of Deferred Charges' 5-year high stood at $75000.0 during Q1 2022, with a 5-year trough of $20000.0 in Q2 2025.
  • Its 5-year average for Amortization of Deferred Charges is $41705.9, with a median of $44000.0 in 2022.
  • In the last 5 years, Nephros' Amortization of Deferred Charges skyrocketed by 5434.78% in 2022 and then crashed by 5434.78% in 2024.
  • Nephros' Amortization of Deferred Charges (Quarter) stood at $74000.0 in 2021, then crashed by 40.54% to $44000.0 in 2022, then fell by 6.82% to $41000.0 in 2023, then plummeted by 43.9% to $23000.0 in 2024, then fell by 4.35% to $22000.0 in 2025.
  • Its Amortization of Deferred Charges stands at $22000.0 for Q3 2025, versus $20000.0 for Q2 2025 and $23000.0 for Q1 2025.